While AD is a complex, multifactorial disease, evidence supports the hypothesis that NMDA receptor hypofunction may be one pathophysiological underpinning [46,77,81], and patients with AD have reduced gene expression of the GluN1 subunit compared to age-matched controls [40]. This evidence concerns the gene GRIN1 and Alzheimer disease.